Cited by 43Radiomics and Machine Learning in Medical ImagingAI in cancer detectionLung Cancer Diagnosis and Treatment

DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network

Open access
Lee, Bora, Chun, Sang Hoon, Hong, Ji Hyung, Woo, In Sook, Kim, Seoree, Jeong, Joon Won, Kim, Jae Jun, Lee, Hyun Woo +6 more·2020·Scientific Reports

Abstract

Accurate prediction of non-small cell lung cancer (NSCLC) prognosis after surgery remains challenging. The Cox proportional hazard (PH) model is widely used, however, there are some limitations associated with it. In this study, we developed novel neural network models called binned time survival analysis (DeepBTS) models using 30 clinico-pathological features of surgically resected NSCLC patients (training cohort, n = 1,022; external validation cohort, n = 298). We employed the root-mean-square error (in the supervised learning model, s- DeepBTS) or negative log-likelihood (in the semi-unsupervised learning model, su-DeepBTS) as the loss function. The su-DeepBTS algorithm achieved better performance (C-index = 0.7306; AUC = 0.7677) than the other models (Cox PH: C-index = 0.7048 and AUC = 0.7390; s-DeepBTS: C-index = 0.7126 and AUC = 0.7420). The top 14 features were selected using su-DeepBTS model as a selector and could distinguish the low- and high-risk groups in the training cohort (p = 1.86 × 10−11) and validation cohort (p = 1.04 × 10−10). When trained with the optimal feature set for each model, the su-DeepBTS model could predict the prognoses of NSCLC better than the traditional model, especially in stage I patients. Follow-up studies using combined radiological, pathological imaging, and genomic data to enhance the performance of our model are ongoing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-58722-z

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [6]Lee, C., Zame, W. R., Yoon, J. & van der Schaar, M. In Thirty-Second AAAI Conference on Artificial Intelligence (2018).
  2. [14]Amin, M. B. et al. Eds. AJCC Cancer Staging Manual. (Springer, 2017).

Cited by

Sorted by citations

Authors
Lee, B., Chun, S. H., Hong, J. H., Woo, I. S., Kim, S., Jeong, J. W., Kim, J. J., Lee, H. W., Na, S. J., Beck, K. S., Gil, B., Park, S., An, H. J., & Ko, Y. H.
Affiliations
  • Deargen (South Korea) (KR)
  • Catholic University of Korea (KR)
  • Ajou University (KR)
Corresponding author
  • An, Ho Jung
  • Ko, Yoon Ho
Venue
Scientific Reports
Published
2020-02-06
Volume
10
Issue
1
Pages
1952-1952
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3004869489
Cited by
43
References
12
Citations by year
2026: 2 · 2025: 4 · 2024: 9 · 2023: 9 · 2022: 6 · 2021: 9 · 2020: 4
FWCI
3.39
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • AJOU Open Repository (Ajou University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National R&D Program for Cancer Control, Ministry of Health&Welfare, Republic of Korea
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords
non-small cell lung cancer, recurrence-free survival, outcome prediction, feature selection, risk stratification, stage I lung cancer
MeSH terms
Adult, Aged, Aged, 80 and over, Algorithms, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Prognosis, Cohort Studies, Proportional Hazards Models, Survival Analysis, Neural Networks, Computer, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review